510(k) K203833
K203833 is an FDA 510(k) premarket notification submitted by Shanghai Genext Medical Technology Co., Ltd. for the device "Tacrolimus Assay Kit". The FDA issued a decision of Substantially Equivalent on January 27, 2023. The device falls under product code MLM (Enzyme Immunoassay, Tracrolimus), a Class II device regulated under 21 CFR 862.1678.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 27, 2023
- Date Received
- December 30, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Tracrolimus
- Device Class
- Class II
- Regulation Number
- 862.1678
- Review Panel
- TX
- Submission Type